Verition Fund Management’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-94,866
Closed -$953K 2659
2022
Q4
$953K Sell
94,866
-88,025
-48% -$874K 0.01% 929
2022
Q3
$1.8M Hold
182,891
0.02% 982
2022
Q2
$1.79M Sell
182,891
-2,908
-2% -$28.4K 0.04% 726
2022
Q1
$1.81M Buy
185,799
+56,327
+44% +$547K 0.02% 1044
2021
Q4
$1.25M Buy
129,472
+2,908
+2% +$28.3K 0.01% 1150
2021
Q3
$1.23M Sell
126,564
-126,464
-50% -$1.23M 0.01% 843
2021
Q2
$2.45M Buy
+253,028
New +$2.48M 0.02% 449

Other funds holding AONC

Verition Fund Management's AONC Position: Q1 2023 in Review

Verition Fund Management sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 94,866 shares — an estimated $953K sold.

Verition Fund Management first reported a position in AONC in Q2 2021 and held it in 7 quarters. The position peaked at $2.45M in Q2 2021. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.

  • Verition Fund Management reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Verition Fund Management sold 94,866 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $953K.
  • Verition Fund Management first reported a position in American Oncology Network, Inc. Class A Common Stock in Q2 2021 and held it in 7 quarters.
  • Verition Fund Management's American Oncology Network, Inc. Class A Common Stock position peaked at $2.45M in Q2 2021.
  • 13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.

Based on Verition Fund Management's 13F filing for Q1 2023, filed 15 May 2023.